Authors: Shaughnessy, JD Barlogie, B

Citation: Jd. Shaughnessy et B. Barlogie, Developmental therapeutics for multiple myeloma - A road map for the future, SEM HEMATOL, 38(3), 2001, pp. 295-297

Authors: Sawyer, JR Lukacs, JL Thomas, EL Swanson, CM Goosen, LS Sammartino, G Gilliland, JC Munshi, NC Tricot, G Shaughnessy, JD Barlogie, B

Citation: Jr. Sawyer et al., Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma, BR J HAEM, 112(1), 2001, pp. 167-174

Authors: Tian, EM Sawyer, JR Largaespada, DA Jenkins, NA Copeland, NG Shaughnessy, JD

Citation: Em. Tian et al., Evi27 encodes a novel membrane protein with homology to the IL17 receptor, ONCOGENE, 19(17), 2000, pp. 2098-2109

Authors: Li, JY Shen, H Himmel, KL Dupuy, AJ Largaespada, DA Nakamura, T Shaughnessy, JD Jenkins, NA Copeland, NG

Citation: Jy. Li et al., Leukaemia disease genes: large-scale cloning and pathway predictions, NAT GENET, 23(3), 1999, pp. 348-353

Authors: Shaughnessy, JD Largaespada, DA Tian, EM Fletcher, CF Cho, BC Vyas, P Jenkins, NA Copeland, NG

Citation: Jd. Shaughnessy et al., Mrvil, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1, ONCOGENE, 18(12), 1999, pp. 2069-2084